Not exact matches
Tumors that originate in other organs of the body and spread to the brain are known as metastatic brain t
Tumors that originate
in other organs of the body and spread to the
brain are known as
metastatic brain tumorstumors.
Published
in the February 27 issue of Cell, the study found that
tumor cells that reach the
brain — and successfully grow into new
tumors — hug capillaries and express specific proteins that overcome the
brain's natural defense against
metastatic invasion.
Dr. Massagué is particularly interested
in the ability of
tumor cells to hug blood vessels, as he suspects this behavior may be essential for the survival of
metastatic cancer cells not only
in the
brain but also
in other parts of the body where
metastatic tumor growth can occur.
The MRI imaging detected
metastatic tumors, including micrometastases,
in lung, liver, lymph node, adrenal gland, bone, and
brains of the mice.
Similar to high - grade gliomas, which originate
in the
brain, these
metastatic brain tumors are lethal, and there are very few therapeutic options.
In early clinical trials, Sessler and his colleagues treated 39
metastatic brain tumor patients with texaphyrins 2 hours before radiation therapy for 10 days.
CSCs were prepared from 231BrM and CN34BrM cells that were infected with lentivirus carrying with or without miR -7-2, and they were transplanted into nude mice through intracardiac injection followed by monitoring
metastatic tumor growth
in the
brain.
We also examined the expression of miR - 7 and KLF4
in brain -
metastatic lesions and found that these genes were significantly down - or upregulated, respectively,
in the
tumor cells
in brain.
After 5 weeks,
metastatic tumor growth
in the
brain was prominent
in all mice that received CSCs carrying vector only.
After first verifying that stem cells injected to the
brain would travel to multiple
metastatic sites and not to
tumor - free areas
in their model, the team injected stem cells loaded with oHSV into the carotid artery of metastasis - bearing mice..
Furthermore, we examined the expression of KLF4
in brain metastatic tissues by immunohistochemistry and found that KLF4 was expressed more
in the nucleus and significantly less
in cytosol
in brain metastatic tissues compared with primary
tumors (Fig. 6C and D).
They found that injecting into the carotid artery breast cancer cells that express markers allowing them to enter the
brain — cells labelled with bioluminescent and fluorescent markers to enable tracking by imaging technologies — resulted
in the formation of many
metastatic tumors throughout the
brain, mimicking what is seen
in advanced breast cancer patients.
To further validate the clinical significance of miR - 7 and KLF4
in brain metastasis of breast cancer, we microdissected
tumor tissues from both primary and
brain metastatic lesions followed by conducting TaqMan qRT - PCR.
They found that injecting patient - derived,
brain - seeking melanoma cells into the carotid artery of these preclinical models resulted
in the formation of many
metastatic tumors throughout the
brain, mimicking what is seen
in advanced melanoma cancer patients.
We found that the expression of miR - 7 was significantly lower
in brain metastatic tumors than that
in primary
tumor tissues (Fig. 6A, left), whereas the expression of KLF4 was significantly higher
in brain metastatic tissue compared with primary
tumors (Fig. 6A, right).
«
Metastatic brain tumors — often from lung, breast or skin cancers — are the most commonly observed
tumors within the
brain and account for about 30 percent of advanced breast cancer metastases,» says Khalid Shah, MS, PhD, director of the Molecular Neurotherapy and Imaging Laboratory
in the MGH Departments of Radiology and Neurology, who led the study.
Generally, treatment of
metastatic brain tumors will include surgery, stereotactic radiosurgery, conventional radiation therapy and chemotherapy, each used independently or
in combination.
I then transitioned to a dedicated surgical neuro - oncology fellowship at the University of Miami, where I gained significant experience
in treating malignant
brain tumors, developing clinical trials, and delivering minimally invasive therapies for both primary and
metastatic tumors of the central nervous system.
The Program specializes
in the treatment of primary head and neck cancers,
brain and spine
tumors such as squamous cell carcinoma, basal cell cancer, glomus
tumor, paragangliomas, acoustic neuromas, salivary gland and mucosal
tumors, astrocytomas, oligodendrogliomas, glioblastomas, and hemangioblastomas, and
metastatic tumors that may have arisen from elsewhere
in the body such as the breast, lung, or prostate.
Brain Tumors Tumors in the brain may occur in dogs as primary or as metastatic tu
Brain Tumors Tumors in the brain may occur in dogs as primary or as metastatic t
Tumors Tumors in the brain may occur in dogs as primary or as metastatic t
Tumors in the
brain may occur in dogs as primary or as metastatic tu
brain may occur
in dogs as primary or as
metastatic tumorstumors.
Secondary or
metastatic brain tumors originate from malignant
tumors (cancers) located primarily
in other organs and metastasize (spread) to the
brain.